Exagen (XGN) Balance Sheet: Assets & Liabilities

Exagen (XGN) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Exagen reported total assets of $58.02M and total liabilities of $40.57M. Shareholders' equity was $17.45M, up 82.9% from $9.54M a year earlier. Total debt stood at $22.91M against $32.22M in cash and short-term investments, a net cash position of $9.31M. That puts debt-to-equity at 1.31, compared with 2.43 a year earlier.

Exagen Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Exagen Inc. (XGN) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	32.22	22.04	36.49	62.39	99.44	57.45	72.08	13.16	11.24
Cash & Short-Term Investments	32.22	22.04	36.49	62.39	99.44	57.45	72.08	13.16	11.24
Accounts Receivable	10.86	7.84	6.55	6.08	9.65	8.91	5.72	5.95	0.60
Inventory	0.00	0.00	0.00	1.80	1.09	0.00	0.00	1.02	0.54
Other Current Assets	0.04	6.58	1.93	0.24	3.64	4.16	3.45	2.20	1.42
Total Current Assets	48.89	36.46	47.84	72.61	112.73	70.52	81.25	21.31	13.26
Non-Current Assets
Property, Plant & Equipment (Net)	8.37	7.68	8.49	13.08	4.77	2.10	1.38	1.57	1.34
Long-Term Investments	0.20	0.00	0.00	0.00	0.00	0.00	0.00	0.10	0.10
Goodwill	0.00	0.00	0.00	0.00	5.51	5.51	5.51	5.51	5.51
Intangible Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.14
Other Non-Current Assets	0.76	0.55	0.62	0.53	0.43	0.25	0.17	-0.02	-0.35
Total Non-Current Assets	9.13	8.23	9.10	13.61	10.71	7.86	7.06	7.58	7.13
Total Assets	58.02	44.69	56.94	86.22	123.45	78.38	88.31	28.89	20.39
Current Liabilities
Accounts Payable	4.15	4.14	3.13	3.05	2.49	3.01	1.48	1.28	1.77
Short-Term Debt	0.64	1.72	0.26	0.19	0.59	0.31	0.24	0.08	0.03
Current Portion of Long-Term Debt	0.64	0.42	0.26	0.19	-	-	-	-	-
Accrued Liabilities	6.33	6.92	7.53	4.20	6.83	5.45	-	-	-
Deferred Revenue	0.68	0.73	0.00	0.00	0.00	0.00	0.00	3.84	0.00
Other Current Liabilities	6.33	6.92	0.30	0.45	6.24	5.45	4.18	7.59	3.19
Total Current Liabilities	14.16	13.51	11.90	9.62	9.32	8.77	5.90	8.95	4.99
Non-Current Liabilities
Long-Term Debt	22.26	21.49	19.23	28.78	27.48	26.66	25.85	24.90	18.89
Deferred Tax Liabilities	0.00	0.00	0.00	0.00	0.31	0.16	0.26	0.25	0.21
Other Non-Current Liabilities	1.96	0.16	0.36	0.87	1.41	0.95	0.64	-1.23	-0.64
Total Non-Current Liabilities	26.41	21.64	22.35	34.14	29.19	27.77	26.76	26.67	20.04
Total Liabilities	40.57	35.15	34.25	43.76	38.51	36.54	32.65	35.62	25.03
Stockholders' Equity
Common Stock	0.02	0.02	0.02	0.02	0.02	0.01	0.01	0.01	0.01
Retained Earnings	-314.28	-294.33	-279.22	-255.53	-208.14	-181.29	-164.60	-152.56	-147.64
Accumulated Other Comprehensive Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-1.82	-2.18
Additional Paid-in Capital	331.71	303.85	301.89	297.97	293.06	223.12	220.25	40.59	50.94
Shares Outstanding	22.91	17.64	17.05	16.55	16.16	-	-	-	-
Total Stockholders' Equity	17.45	9.54	22.69	42.46	84.94	41.84	55.66	-6.73	-4.64
Total Liabilities & Equity	58.02	44.69	56.94	86.22	123.45	78.38	88.31	28.89	20.39

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Exagen Balance Sheet

How much debt does Exagen have?

Exagen had total debt of $22.91M as of Dec 31, 2025, against $32.22M in cash and short-term investments. Its debt-to-equity ratio was 1.31. Total debt was $23.21M a year earlier.

What are Exagen's total assets?

Exagen reported total assets of $58.02M as of Dec 31, 2025, up 29.8% from $44.69M a year earlier. Total liabilities were $40.57M.

What is Exagen's shareholders' equity?

Exagen's shareholders' equity was $17.45M as of Dec 31, 2025, or about $0.76 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition